STOCK TITAN

Corcept (NASDAQ: CORT) exec sells 10,000 shares at $116

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

CORCEPT THERAPEUTICS INC (CORT) reported insider transactions by Chief Business Officer Gary Charles Robb. On 2026-08-17, he made a bona fide gift of 125 common shares, leaving 13,426 shares held directly, which include multiple unvested restricted stock awards that vest one year after their grant dates, subject to conditions. The same day, an entity associated with him, the Gary Charles Robb TTE Robb Revocable Trust, sold 10,000 common shares at a weighted average price of $116.2572 per share (range $116.00–$116.54), resulting in 39,716 shares held indirectly through the trust. Additional shares are held in custodial accounts for his children under the Uniform Transfers to Minors Act, where he acts as custodian.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Robb Gary Charles
Role Chief Business Officer
Sold 10,000 shs ($1.16M)
Type Security Shares Price Value
Gift Common Stock F1 125 $0.00 $0.00
Sale Common Stock F2, F3 10,000 $116.2572 $1.16M
holding Common Stock F4 -- -- --
holding Common Stock F5 -- -- --
Holdings After Transaction: Common Stock — 13,426 shares (Direct); Common Stock — 39,716 shares (Indirect, Gary Charles Robb TTE Robb Revocable Trust); Common Stock — 31,142 shares (Indirect, Custodial Account for Child)
Footnotes (5)
  1. F1. Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
  2. F2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
  3. F3. These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.
  4. F4. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
  5. F5. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
Shares sold 10,000 shares Common Stock sold indirectly through revocable trust on 2026-08-17
Weighted average sale price $116.2572 per share Weighted average price for 10,000 shares sold; prices ranged $116.00–$116.54
Gifted shares 125 shares Bona fide gift of Common Stock on 2026-08-17
Direct holdings after gift 13,426 shares Directly held CORT Common Stock following the gift transaction, including unvested RSAs
Indirect holdings after sale 39,716 shares Shares held indirectly through Gary Charles Robb TTE Robb Revocable Trust after sale
Sale price range $116.00–$116.54 per share Range of individual prices for the 10,000 shares sold on 2026-08-17
bona fide gift financial
"transaction_code_description: "Bona fide gift" for 125-share transfer"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
weighted average sale price financial
"Represents the weighted average sale price for the entire number of shares sold."
restricted stock awards financial
"Includes shares underlying unvested restricted stock awards granted to the Reporting Person"
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
Revocable Trust financial
"These shares are held by Gary Charles Robb TTE Robb Revocable Trust"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
Uniform Transfers to Minors Act financial
"custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."

FAQ

What insider transactions did CORT’s Chief Business Officer report on this Form 4?

The CORT Chief Business Officer reported a bona fide gift of 125 shares and a sale of 10,000 shares of common stock on 2026-08-17. The sale was executed through a revocable trust associated with him.

How many CORT shares did the insider sell and at what price?

The insider-related trust sold 10,000 shares of CORT common stock at a weighted average price of $116.2572 per share. The actual sale prices ranged between $116.00 and $116.54 per share, based on multiple individual trades.

What are the insider’s CORT shareholdings after these transactions?

After the reported transactions, the insider directly holds 13,426 shares of CORT common stock and indirectly holds 39,716 shares through a revocable trust. Some additional shares are held in custodial accounts for his children.

Were any CORT shares transferred as a gift in this Form 4?

Yes. The filing reports a bona fide gift of 125 shares of CORT common stock on 2026-08-17. Following this gift, the insider’s directly held position totaled 13,426 shares, including unvested restricted stock awards.

How are unvested restricted stock awards described in this CORT Form 4?

The direct holdings include shares underlying restricted stock awards granted on four dates in 2025–2026. 100% of the shares underlying each award vest on the one-year anniversary of its grant date, subject to specified requirements.

Were the reported CORT trades under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not marked as true, so these transactions are not affirmatively reported as being made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Robb Gary Charles

(Last)(First)(Middle)
C/O CORCEPT THERAPEUTICS INCORPORATED
101 REDWOOD SHORES PARKWAY

(Street)
REDWOOD CITY CALIFORNIA 94065

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CORCEPT THERAPEUTICS INC [ CORT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Business Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/17/2026G125D$0.0013,426(1)D
Common Stock08/17/2026S10,000D$116.2572(2)39,716IGary Charles Robb TTE Robb Revocable Trust(3)
Common Stock15,571ICustodial Account for Child(4)
Common Stock15,571ICustodial Account for Child(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
3. These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.
4. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
5. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
Remarks:
The power of attorney under which this form was signed is on file with the Commission.
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)